darolutamide
bayer
[]
arasens: association of psa resp &amp; os daro: time to psa progress (hr 0.26, 95%ci 0.21 0.31) undetec psa @ 24 wks: daro 48.7% vs pbo 23.9% os: for pts w/ undet psa vs not @ 24 weeks (hr 0.47, 95%ci 0.35 0.63) &amp; 36 weeks (hr 0.37, 95%ci 0.28 0.49) #asco22 
Uro Onc @GACancerCenter | Res PD & Ronald W. Lewis MD Chair of Uro Educ @mcg_urology | Digital Media Ed @EUplatinum | #mentalhealth research | @urotoday